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Review of the usefulness of contacting other experts when
conducting a literature search for systematic reviews
R J McManus, S Wilson, B C Delaney, D A Fitzmaurice, C J Hyde, R S Tobias, S Jowett, F D R Hobbs
Introduction
Identifying relevant studies is “the most fundamental
challenge” when compiling a systematic review.1
Electronic databases, such as Medline, may detect only
about half of papers identified by the gold standard of
hand searching journals.1 Hand searching requires a
focus, usually the specialist literature,2 which may not
exist for newly developed fields or those that cross
boundaries with other areas. We examined the
usefulness of contacting other experts when searching
for relevant references for a systematic review of a field
where such a specialist focus does not exist.
Methods and results
As part of a systematic review undertaken in 1996, all
published literature relating to “near patient testing”
(any investigation performed in a clinical setting where
the result is available without a sample being sent to a
laboratory for analysis) in primary care was identified for
1986›95.3 Electronic databases were searched and
secondary citations were collected from identified publi›
cations (see table). The search strategy is reported
elsewhere.3 Indexes of abstracts from major inter›
national primary care scientific conferences were hand
searched. We sent a questionnaire to 194 academics in
the United Kingdom (heads of academic departments
of general practice and clinical chemistry and research›
ers identified from the previously mentioned abstracts)
and to 152 commercial companies known to have an
interest in near patient testing. The questionnaire
requested key references from journals, unpublished
data, and names of other workers in the field.
Overall, 156 (45%) questionnaires were returned
completed (103 (53%) of those sent to academics and
53 (35%) of those sent to commercial companies). No
unpublished data were offered.
Articles that did not report original data, were not
relevant to primary care, or were not in English were
excluded. Remaining articles were then judged by both
an external and internal reviewer against standard
appraisal criteria,4 with discrepancies being adjudi›
cated on by a third reviewer (BCD). A verifying search
did not identify any further key words or references.
The searches yielded 1286 citations comprising
1057 unique references potentially eligible for
inclusion in the review. The table shows a breakdown of
the results by source—102 references were relevant, of
which 29 were of high quality. Of the 102 unique eligi›
ble references, 50 (49%) were identified by one of the
electronic databases, 40 (39%) by people working in
the field, and 31 (30%) by hand searches. Each of these
sources produced a similar proportion of high quality
papers.
The 1057 potential references came from 418
different publications, of which only 48 were found to
contain relevant articles. Only one journal, the BMJ,
contained more than 10% (11 articles) of the relevant
references.
Comment
This study confirms that searching electronic databases
may uncover only half of all relevant studies1 and
shows the importance of contacting other experts
when compiling a systematic review. Over 300 of the
references in this review were identified by experts
working in the field, of which 40 were found
subsequently to be eligible. Twenty four references
(24% of the total number of eligible references) would
have been missed entirely without the input of people
working in the field.
The lack of sensitivity of electronic databases may
be due to problems with indexing5: articles from jour›
nals that lie outside of the mainstream (which currently
includes primary care) take some years to be electroni›
cally indexed; furthermore, near patient testing is an
expanding field without unique medical subject
headings (MeSH terms). The continuing work of the
Cochrane Collaboration is improving this situation,5
but at the time of this study, making up the shortfall in
articles by hand searching would not have been justifi›
able in terms of either time or money.
Results of various types of search
Search
No of
articles
identified
No of articles
eligible in
review
Unique
articles
identified
High quality
articles*
Electronic databases
BIDS Science Citation Index 185 32 15 5
Medline 335 20 11 9
Embase 40 11 5 4
CINAHL 48 0 0 0
BIDS index to conference proceedings 32 0 0 0
GPLit 26 0 0 0
DHSS 18 0 0 0
PsychLit 10 0 0 0
Total No of articles 694 63 31 18
No of unique articles 581 50 31 15
Survey of expert network
Academics 297 37 20 7
Commercial organisations 43 4 3 2
Total No of articles 340 41 23 9
No of unique articles 338 40 23 9
Hand searching†
Abstracts 44 0 0 0
Reports 29 7 1 2
References 129 24 20 8
Total No of articles (all unique) 202 31 21 10
Overall results
Total citations identified 1236 135 75 37
Total unique references‡ 1057 102 75 29
*Eligible papers scoring 4 or 5 for methodology (one point was given for each of the following: an
independent blind comparison to a reference standard; an appropriate spectrum of patients in the sample;
reference standard performed on all patients; test methods described sufficiently to permit replication;
likelihood ratios quoted).
†Limited hand search of published abstracts of international primary care meetings, and bibliographies of
publications identified from above sources.
‡Excluding overlaps between the three search methods.
Papers
Department of
Primary Care and
General Practice,
University of
Birmingham,
Birmingham
B15 2TT
R J McManus,
clinical research fellow
S Wilson,
research fellow
B C Delaney,
senior lecturer
D A Fitzmaurice,
senior lecturer
R S Tobias,
research associate
S Jowett,
research associate
F D R Hobbs,
professor
continued over
BMJ 1998;317:1562–3
1562 BMJ VOLUME 317 5 DECEMBER 1998 www.bmj.com
 on 29 January 2008 bmj.comDownloaded from 
This study has quantified the contribution of experts
to a systematic review and has found them to be an
essential source for identifying literature. We suggest that
appropriate experts should be consulted when perform›
ing a systematic review in a developing field that does
not have a clearly defined specialist literature.
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Drug points
Anaphylaxis induced by gabexate mesylate
Yoshihiro Matsukawa, Susumu Nishinarita, Takashi Horie, Sensuke
Naruse, Nihon University School of Medicine, Oyagochi›Kamimachi
Itabashi, 173 Tokyo, Japan
Gabexate mesylate (molecular weight 417) is a protease
inhibitor1 2 and has an effect against shock.3 Ten cases of
shock induced by gabexate mesylate have, however, been
reported (Ono Pharmaceutical Company and Nichiiko
Pharmaceutical Company, personal communication). We
report an additional case and an analysis of the clinical
features of the 11 cases.
A 59 year old woman (case 7 in table) developed
pancreatitis in 1975. She visited our clinic because of
epigastralgia in October 1996. Laboratory tests showed
raised concentrations of amylase (123 IU/l in serum, 857
IU/l in urine; normal values < 120 IU/l and < 700 IU/l).
She received an infusion of gabexate mesylate (100 mg),
which resolved her symptoms. She re›experienced abdomi›
nal pain in February 1997, which was relieved with the same
treatment. This time, however, she developed urticaria after
the gabexate mesylate infusion. She developed another
bout of epigastralgia one week after this episode. She again
developed urticaria 10 minutes after the initiation of the
infusion and subsequently experienced chest constriction.
Injection of hydrocortisone caused no improvements.
Finally, she became pale and drowsy. Her systolic blood
pressure fell to 90 mm Hg and became normal 30 minutes
after receiving additional injections of hydrocortisone and
noradrenaline (norepinephrine). Results of a lymphocyte
stimulation test against gabexate mesylate were negative.
Her serum concentration of IgE was within the normal
range.
Ten of the 11 patients were re›exposed to gabexate
mesylate. Nine patients developed eruptions. In three
patients urticaria preceded the signs of anaphylaxis. Shock
developed within 30 minutes after the challenge in all
patients, with the signs of anaphylaxis—that is, hypoten›
sion and erythema or urticaria induced by the hypersecre›
tion of histamine (table). All patients recovered from the
shock, although two patients required intubation and
artificial ventilation.
Patients who are repeatedly treated with gabexate
mesylate should be carefully monitored for at least 30
minutes after administration of the drug. Use of
corticosteroids and adrenaline (epinephrine) and respira›
tory care seems to be adequate for treating such patients.
1 Buchler M, Malfertheiner P, Uhl W, Scholmerich J, Stockmann F, Adler G,
et al. Gabexate mesilate in human acute pancreatitis. Gastroenterology
1993;104:1165›70.
2 Cavallini G, Tittobello A, Frulloni L, Masci E, Marlani A, DiFrancessi V,
Gabexate in Digestive Endoscopy—Italian Group. Gabexate for the
prevention of pancreatic damage related to endoscopic retrograde
cholangiopancreatography. N Engl J Med 1996;335:919›23.
3 Novelli GP, Casali R, Bonizzoli M, Giorgi L, Lemma M, Piscitelli P.
Antioxidant action of gabexate mesilate (FOY) in an experimental model
of endotoxin shock. Minerva Anestesiol 1995;61:509›13.
Clinical manifestations of shock induced by gabexate mesylate
Case
Age
(years) Sex
Blood pressure
(mm Hg) Eruption Urticaria
Disturbance in
consciousness
Time of onset
(minutes)
1 26 F 60/0 ++ NR › <5
2 46 F UD + NR + <30
3 46 M 50/0 NR NR › <5
4 48 M UD + + + <5
5 54 M 60/0 ++ NR › <5
6 57 M 60/0 + + › 5
7* 59 F 90/0 ++ ++ + <30
8 60 M 55/26 ++ NR › 5
9 65 M UD ++ NR + 5
10 73 F 80/42 NR NR NR 5
11 76 F 44/0 + + + 30
NR=not reported; UD= not detectable. *Current case.
Endpiece
Orifices
First, there are orifices where we hear. For the area round the ear is hollow
and hears nothing but noise and shouting. But whatever penetrates
through the membrane to the brain is clearly heard there. This is the only
perforation through the membrane which encloses the brain. At the
nostrils there is no (such) opening but a soft area, like sponges. For this
reason we hear over a greater distance than we smell.
Hippocrates, Places in Man, edited and translated by
Elizabeth M Craik, 1998
Submitted by Ann Dally, Wellcome Institute for the History of Medicine
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